Trelagliptin is a long-acting DPP-4 inhibitor that can prolong the existence of insulin in the human body, but its hypoglycemic effect is similar to that of short-acting DPP-4 inhibitors, and cannot completely replace other oral hypoglycemic drugs, let alone insulin, the main advantage of Trelagliptin is that it is easy to take.